54-21-7
S2679
98.0-102.0% anhydrous basis, meets USP testing specifications
1614636
United States Pharmacopeia (USP) Reference Standard
567630
A cell-permeable, non-steroidal anti-inflammatory agent that interferes with TNF-induced NF-κB activation by inhibiting phosphorylation and subsequent degradation of the IκB-α protein.
71945
≥99.5% (HPLC), puriss. p.a.
31493
puriss. p.a., reag. Ph. Eur., 99.5-101.0% (calc. to the dried substance)
PHR3238
pharmaceutical secondary standard, certified reference material
S0800000
European Pharmacopoeia (EP) Reference Standard